HCA
MURA

Harbor Capital Advisors’s Mural Oncology MURA Stock Holding History

Harbor Capital Advisors’s Portfolio MURA Stock Details MURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-36,769
Closed -$115K – 1354
2024
Q2 		$115K Buy
36,769
+19,116
+108% +$70.5K 0.01% 698
2024
Q1 		$86K Buy
+17,653
New +$85.7K 0.01% 715

Other funds holding MURA

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFA
Alta Fundamental Advisers New York $265M AUM 98.61% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Harbor Capital Advisors's MURA Position: Q3 2024 in Review

Harbor Capital Advisors sold out of Mural Oncology (MURA) in Q3 2024, closing a stake of 36,769 shares — an estimated $115K sold.

Harbor Capital Advisors first reported a position in MURA in Q1 2024 and held it in 2 quarters. The position peaked at $115K in Q2 2024. 74 funds tracked by Wall St. Rank hold MURA as of Q3 2024.

  • Harbor Capital Advisors reported no remaining Mural Oncology position as of Q3 2024 after selling out during the quarter.
  • Harbor Capital Advisors sold 36,769 Mural Oncology shares in Q3 2024, an estimated $115K.
  • Harbor Capital Advisors first reported a position in Mural Oncology in Q1 2024 and held it in 2 quarters.
  • Harbor Capital Advisors's Mural Oncology position peaked at $115K in Q2 2024.
  • 74 funds tracked by Wall St. Rank held Mural Oncology as of Q3 2024.

Based on Harbor Capital Advisors's 13F filing for Q3 2024, filed 29 Oct 2024.